USPTO 2015–2025 USPTO PatentsView Foreign Corporation

TecPharma Licensing AG

USPTO PatentsView assignee record - 54 granted patents across 8 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Tecpharma ranks #6,289 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 8 technology areas.

#6,289
of 49,997 US assignees by volume
48th percentile
by Innovation Score (34.5/100)
17.7
avg claims per patent
-80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6289 · Foreign Corporation #6,289 · 54 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 54 grants
  • UPPER-Q #6,289/49,997
  • PHOTO-FINISH Takara Bio USA
  • CPC-NARROW A61M · 8 areas
  • INNOV-THIN 34.5/100
  • CLAIMS-RICH 17.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -80% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Takara Bio USA, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tecpharma’s 34.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Tecpharma

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tecpharma's Innovation Score is 34.5/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Tecpharma?

Each dot is one of Tecpharma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tecpharma’s own 17.7 claims/patent is ABOVE the 12.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tecpharma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 53.954.054.05454.054.054.1 510152025 Granted patents (volume) Avg claims / patent TLV Co., Ltd. - 54, 5.83TLVToho Titanium Co., Ltd. - 54, 9.26Toho TitaniumTripwire, Inc. - 54, 20.26TripwireTakara Bio USA, Inc. - 54, 20.28Takara Bio USATechnology Partners LLC - 54, 14.93Technology Partne…Tekni-Plex, Inc. - 54, 12.89Tekni-plexThe Secretary of State for Defence - 54, 16.94The Secretary of…Thor Tech, Inc. - 54, 11.85Thor TechTecPharma Licensing AG - 54, 17.72Tecpharma Licensi…
Tecpharma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tecpharma's grants concentrate

TecPharma Licensing AG is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (16 grants) versus a trough of 5 in 2016. By volume, Tecpharma sits between TLV Co., Ltd. and Thor Tech, Inc..

Who files at TecPharma's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows TecPharma holds 54 patents at rank #6,291, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near TecPharma

By rank, the assignees closest to #6,291 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in TecPharma's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for TecPharma, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), TecPharma ranks #133 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Similar claim depth

Nearest assignees by average claims per patent (17.7 here).

Tecpharma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 48th percentile higher than 48% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201520162017201820192020 9
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
TecPharma Licensing AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 18.5%
2016 5 9.3%
2017 5 9.3%
2018 9 16.7%
2019 16 29.6%
2020 9 16.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

TecPharma Licensing AG's patent record in context - here's where to go next.

  • TecPharma Licensing AG's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #6,289 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare TecPharma Licensing AG against TLV Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.